Financing Biotechnology in a Risk-Averse Environment
نویسندگان
چکیده
منابع مشابه
Financing Development Stage Biotechnology Companies: RMs vs
We examine reverse mergers (RMs) in the biotechnology industry and find that, when compared to initial public offerings (IPOs), RMs are smaller, have significantly lower market valuations relative to size, and generally invest less. We also find that RMs exhibit positive abnormal returns on the announcement date and throughout the first year after the RM event. In looking at liquidity measures,...
متن کاملRisk Averse Inventory Management∗
Traditional inventory models focus on risk neutral decision makers, i.e., characterizing replenishment strategies that maximize expected total profit, or equivalently, minimize expected total cost over a planning horizon. In this paper, we propose a general framework for incorporating risk aversion in multi-period inventory models as well as multi-period models that coordinate inventory and pri...
متن کاملRisk Averse Shape Optimization
Risk-averse optimization has attracted much attention in nite-dimensional stochastic programming. In this paper, we propose a risk-averse approach in the in nite dimensional context of shape optimization. We consider elastic materials under stochastic loading. As measures of risk awareness we investigate the expected excess and the excess probability. The developed numerical algorithm is based ...
متن کاملComparison of p300 in risk-seeker and risk-averse people during simple gambling task
Risk preference, the degree of tendency to take risk, has a fundamental role at individual and social health and is divided to risk seeker and risk averse. Therefore, the study of neural corelates of risk preferences is essential at the field of psychology and psychiatry. The current study aimed to examine and compare an ERP component named P300 between subjects with different risk preferences....
متن کاملRisk-Averse Production Planning
We consider a production planning problem under uncertainty in which companies have to make product allocation decisions such that the risk of failing regulatory inspections of sites and consequently losing revenue is minimized. In the proposed decision model the regulatory authority is an adversary. The outcome of an inspection is a Bernoulli-distributed random variable whose parameter is a fu...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nature Biotechnology
سال: 1988
ISSN: 1087-0156,1546-1696
DOI: 10.1038/nbt0988-1120